• SPX
  • $5,408.42
  • -1.73 %
  • -$94.99
  • DJI
  • $40,345.41
  • -1.01 %
  • -$410.39
  • N225
  • $35,613.32
  • -2.14 %
  • -$778.15
  • FTSE
  • $8,181.47
  • -0.73 %
  • -$60.24
  • IXIC
  • $16,690.83
  • -2.55 %
  • -$436.87
Poseida Therapeutics, Inc. (PSTX) Competitors

Poseida Therapeutics, Inc. (PSTX) Competitors

NASDAQ Currency in USD Disclaimer

Stock Price

$2.73

$0.02

(0.74%)

Day's range
$2.63
Day's range
$2.79

Poseida Therapeutics, Inc. Competitors

Symbol Company Share Price Market Cap P/E Ratio Employee Count Revenue
ANTX
AN2 Therapeutics, Inc. $1.03 $60.55 M -0.81 41 $0
CUE
Cue Biopharma, Inc. $0.59 $71.99 M -1.38 53 $5.49 M
CYTK
Cytokinetics, Incorporated $54.09 $6.05 B -9.78 423 $7.53 M
DYN
Dyne Therapeutics, Inc. $33.03 $3.03 B -7.77 152 $0
FIXX
Homology Medicines, Inc. $0.93 $3.02 M -0.03 7 $1.16 M
GBIO
Generation Bio Co. $2.19 $216.88 M -1.28 174 $5.90 M
GRCL
Gracell Biotechnologies Inc. $10.25 $989.87 M -10.57 314 $0
INAB
IN8bio, Inc. $0.30 $59.13 M -1.49 39 $0
IPSC
Century Therapeutics, Inc. $1.47 $244.54 M -1.32 152 $2.24 M
LTRN
Lantern Pharma Inc. $3.34 $60.03 M -3.44 21 $0
MLYS
Mineralys Therapeutics, Inc. $11.24 $652.38 M -6.03 28 $0
MOLN
Molecular Partners AG $5.46 $135.05 M -2.03 161 $7.04 M
PASG
Passage Bio, Inc. $0.70 $73.04 M -0.77 58 $0
PEPG
PepGen Inc. $8.84 $537.15 M -5.11 72 $0
PHVS
Pharvaris N.V. $19.12 $843.31 M -5.8 83 $0
PLRX
Pliant Therapeutics, Inc. $12.87 $672.63 M -3.9 166 $1.58 M
RVMD
Revolution Medicines, Inc. $41.84 $6.66 B -10.51 443 $11.58 M
RVPH
Reviva Pharmaceuticals Holdings, Inc. $1.35 $42.94 M -0.91 15 $0
STOK
Stoke Therapeutics, Inc. $14.68 $774.50 M -6.14 110 $8.78 M
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.